A new formal definition of CKM syndrome from the American Heart Association reflects the strong interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system.
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) shows that low muscle mass is associated with a two-fold risk of death from cardiovascular disease in individuals with diabetes.
In 2019, there were almost 14 thousand diabetes-related deaths in the UK. That number looks set to rise. Britain currently has 4.3 million registered diabetics, but new analysis from London Medical Laboratory has revealed there are likely to be over one million Brits suffering from undiagnosed type 2 diabetes.
The US Food and Drug Administration gave the SGLT2 inhibitor empagliflozin (Jardiance) a new indication for treating adults with isolated chronic kidney disease.